XEI Scientific Appoint New Distributors for France
News Jan 29, 2014
XEI Scientific has appointed new distributors for France. SAMx Plus offers instrumentation and practical, innovative software for electron microscopy, 3D non-contact surface topography & metrology and X-ray systems. Marc Lalande, Owner of SAMx Plus, is excited by the prospects of teaming up with XEI. "XEI is the technology leader with their Evactron De-Contaminator systems. The products are a natural fit to our current portfolio and we are confident we will be able to help XEI to grow in this market. SAMx are specialists in imaging techniques. Organic contamination may cause artefacts and mask the true image of samples so being able to offer Evactron cleaning, we can help our clients to clean and maintain vacuum quality in their instrumentation. And we can clean the surface of samples before imaging which greatly increases the clarity of the final image."
Speaking about this new agreement, XEI Vice President of Sales & Marketing, Daniel R Kleinen says "SAMx Plus provides us with an extremely experienced and well-qualified partner for the French market. The Evactron De-Contaminator uses a remote RF plasma source to produce gas-phase radicals that flow downstream through the chamber, eliminating contamination by chemical etch. XEI has now sold more than 1850 Evactron systems worldwide solving contamination problems in many different environments using instrumentation such as electron microscopes, FIBs and other vacuum sample chambers.
Molecular Key for Delaying Multiple Sclerosis ProgressionNews
In work just published it was possible to identify a receptor known as P2X4 present in the microglial cells that increases their anti-inflammatory potential in order to reduce the damage in Multiple Sclerosis and, above all, encourage the body's own repair responses.READ MORE
T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's diseaseNews
Researchers in Germany discover a potential new target for treating Parkinson's diseaseREAD MORE
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE